These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 29255837)

  • 1. EU./U.S. CTAD Task Force on Alzheimer's Trial Populations.
    Vellas B; Sampaio C; Bateman R; Boxer A; Carrillo MC; Cummings J; Dubois B; Hampel H; Katz R; Khachaturian Z; Gauthier S; Johnson K; Karlawish J; Mintun M; Petersen R; Rafii M; Robert P; Schneider LS; Siemers E; Sperling R; Tariot P; Touchon J; Weiner M; Andrieu S; Aisen P
    J Prev Alzheimers Dis; 2014; 1(2):110-116. PubMed ID: 29255837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.
    Aisen P; Touchon J; Andrieu S; Boada M; Doody R; Nosheny RL; Langbaum JB; Schneider L; Hendrix S; Wilcock G; Molinuevo JL; Ritchie C; Ousset PJ; Cummings J; Sperling R; DeKosky ST; Lovestone S; Hampel H; Petersen R; Legrand V; Egan M; Randolph C; Salloway S; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2016; 3(2):68-74. PubMed ID: 29210442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in Treatment Development for Neuropsychiatric Symptoms in Alzheimer's Disease: Focus on Agitation and Aggression. A Report from the EU/US/CTAD Task Force.
    Soto M; Abushakra S; Cummings J; Siffert J; Robert P; Vellas B; Lyketsos CG;
    J Prev Alzheimers Dis; 2015 Sep; 2(3):184-188. PubMed ID: 26413494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force.
    Vellas B; Bateman R; Blennow K; Frisoni G; Johnson K; Katz R; Langbaum J; Marson D; Sperling R; Wessels A; Salloway S; Doody R; Aisen P;
    J Prev Alzheimers Dis; 2015 Jun; 2(2):128-135. PubMed ID: 26247004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention trials in Alzheimer's disease: an EU-US task force report.
    Vellas B; Aisen PS; Sampaio C; Carrillo M; Scheltens P; Scherrer B; Frisoni GB; Weiner M; Schneider L; Gauthier S; Gispen-de Wied CC; Hendrix S; Feldman H; Cedarbaum J; Petersen R; Siemers E; Andrieu S; Prvulovic D; Touchon J; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):594-600. PubMed ID: 21925234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer's Disease Task Force.
    Cummings J; Fox N; Vellas B; Aisen P; Shan G
    J Prev Alzheimers Dis; 2018; 5(2):103-109. PubMed ID: 29616703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force.
    Gauthier S; Alam J; Fillit H; Iwatsubo T; Liu-Seifert H; Sabbagh M; Salloway S; Sampaio C; Sims JR; Sperling B; Sperling R; Welsh-Bohmer KA; Touchon J; Vellas B; Aisen P
    J Prev Alzheimers Dis; 2019; 6(3):164-168. PubMed ID: 31062826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force.
    Aisen PS; Siemers E; Michelson D; Salloway S; Sampaio C; Carrillo MC; Sperling R; Doody R; Scheltens P; Bateman R; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2018; 5(3):171-174. PubMed ID: 29972209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Alzheimer's Disease Drug Development Broken? What Must Be Improved.
    Ousset PJ; Cummings J; Delrieu J; Legrand V; Prins N; Winblad B; Touchon J; Weiner MW; Vellas B
    J Prev Alzheimers Dis; 2014; 1(1):40-45. PubMed ID: 29261219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report.
    Gauthier S; Aisen PS; Cummings J; Detke MJ; Longo FM; Raman R; Sabbagh M; Schneider L; Tanzi R; Tariot P; Weiner M; Touchon J; Vellas B;
    J Prev Alzheimers Dis; 2020; 7(3):152-157. PubMed ID: 32420298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.
    Aisen P; Touchon J; Amariglio R; Andrieu S; Bateman R; Breitner J; Donohue M; Dunn B; Doody R; Fox N; Gauthier S; Grundman M; Hendrix S; Ho C; Isaac M; Raman R; Rosenberg P; Schindler R; Schneider L; Sperling R; Tariot P; Welsh-Bohmer K; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2017; 4(2):116-124. PubMed ID: 29186281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology.
    Vellas B; Hampel H; Rougé-Bugat ME; Grundman M; Andrieu S; Abu-Shakra S; Bateman R; Berman R; Black R; Carrillo M; Donohue M; Mintun M; Morris J; Petersen R; Thomas RG; Suhy J; Schneider L; Seely L; Tariot P; Touchon J; Weiner M; Sampaio C; Aisen P;
    J Nutr Health Aging; 2012 Apr; 16(4):339-45. PubMed ID: 22499454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report from the First Clinical Trials on Alzheimer's Disease (CTAD) Asia-China 2018 : Bringing together Global Leaders.
    Chhetri JK; Chan P; Vellas B; Touchon J; Gauthier S
    J Prev Alzheimers Dis; 2019; 6(2):144-147. PubMed ID: 30756122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease.
    Ketter N; Liu E; Di J; Honig LS; Lu M; Novak G; Werth J; LePrince Leterme G; Shadman A; Brashear HR
    J Prev Alzheimers Dis; 2016; 3(4):192-201. PubMed ID: 29199321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.
    Kaye J; Aisen P; Amariglio R; Au R; Ballard C; Carrillo M; Fillit H; Iwatsubo T; Jimenez-Maggiora G; Lovestone S; Natanegara F; Papp K; Soto ME; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2021; 8(4):513-519. PubMed ID: 34585227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amyloid Positron Emission Tomography in the Therapeutic Strategies for Alzheimer's Disease].
    Ishii K
    Brain Nerve; 2017 Jul; 69(7):809-818. PubMed ID: 28739995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.